Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|September 24, 2008
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancerF Caponigro, D Lacombe, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancerF Caponigro, P Comella, A Budillon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I study of vinorelbine and paclitaxel in small-cell lung cancerR V Iaffaioli, G Facchini, A Tortoriello, et al.
International Journal of Oncology|May 14, 2011
Recovery of sensitivity to cisplatinum and epidoxorubicin by ionidamine and interferon in advanced ovarian-cancerR Iaffaioli, A Tortoriello, G Facchini, et al.
Tumori|February 28, 1990
Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulinG Palmieri, C Gridelli, R Pepe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Accelerated split-course (type B) thoracic radiation therapy plus vinorelbine/carboplatin combination chemotherapy in stage III inoperable non-small cell lung cancerR V Iaffaioli, F Caponigro, A Tortoriello, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cellsM Caraglia, G Giuberti, M Marra, et al.
The International Journal of Biological Markers|April 1, 1990
CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)F Caponigro, R V Iaffaioli, C Pagliarulo, et al.
Pageof 5